These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8254656)

  • 1. Computing the structure of bound peptides. Application to antigen recognition by class I major histocompatibility complex receptors.
    Rosenfeld R; Zheng Q; Vajda S; DeLisi C
    J Mol Biol; 1993 Dec; 234(3):515-21. PubMed ID: 8254656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of an antigenic complex between a viral peptide and a class I major histocompatibility glycoprotein.
    Rognan D; Reddehase MJ; Koszinowski UH; Folkers G
    Proteins; 1992 May; 13(1):70-85. PubMed ID: 1594579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of antigenic peptides with the H-2Kd MHC class I molecule.
    Maryanski JL; Lüthy R; Romero P; Healy F; Drouet C; Casanova JL; Jaulin C; Kourilsky P; Corradin G
    Semin Immunol; 1993 Apr; 5(2):95-104. PubMed ID: 8504219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.
    Chen Y; Sidney J; Southwood S; Cox AL; Sakaguchi K; Henderson RA; Appella E; Hunt DF; Sette A; Engelhard VH
    J Immunol; 1994 Mar; 152(6):2874-81. PubMed ID: 8144888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.
    Willcox BE; Thomas LM; Bjorkman PJ
    Nat Immunol; 2003 Sep; 4(9):913-9. PubMed ID: 12897781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
    Matsumura M; Fremont DH; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the calculation of binding free energies using continuum methods: application to MHC class I protein-peptide interactions.
    Froloff N; Windemuth A; Honig B
    Protein Sci; 1997 Jun; 6(6):1293-301. PubMed ID: 9194189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
    Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
    J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.
    Collins EJ; Garboczi DN; Wiley DC
    Nature; 1994 Oct; 371(6498):626-9. PubMed ID: 7935798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural mining: self-consistent design on flexible protein-peptide docking and transferable binding affinity potential.
    Liu Z; Dominy BN; Shakhnovich EI
    J Am Chem Soc; 2004 Jul; 126(27):8515-28. PubMed ID: 15238009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible docking of peptide ligands to proteins.
    Desmet J; De Maeyer M; Spriet J; Lasters I
    Methods Mol Biol; 2000; 143():359-76. PubMed ID: 11084914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.